Allied Health & Imaging · Independent exam preparation
ARRT Radiation Therapy Examination Study Guide
Practise treatment verification, radiation safety, localization and dose calculations with 60 focused concepts and 20 explained ARRT Radiation Therapy drills.
By CertMedbry · Updated 1 November 2026
Build the reasoning needed to match patients with treatment instructions, recognize concerning symptoms, evaluate setup corrections and solve clearly defined dose problems. This guide follows the Radiation Therapy specifications applicable through January 31, 2027, with 14 Patient Care, 15 Safety and 31 Procedures concepts.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and eligibility pathway does this guide address?
The ARRT Radiation Therapy Examination assesses knowledge and cognitive skills for entry-level radiation therapist practice. ARRT identifies Radiation Therapy as a certification and registration discipline using its primary eligibility pathway. This guide does not address a radiography examination, a nursing examination or a separate advanced-practice credential.
ARRT: Radiation Therapy · ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
Which blueprint applies to my examination date?
For examination dates through January 31, 2027, use the specifications approved in January 2021 and implemented January 1, 2022, version V 2021.02.25. The replacement was approved in January 2026 and takes effect February 1, 2027, version V 2026.03.27. This guide uses the earlier, currently applicable weighting.
ARRT: Radiation Therapy · ARRT Radiation Therapy Examination Content Specifications: January 1, 2022 · ARRT Radiation Therapy Examination Content Specifications: February 1, 2027
How many scored and unscored questions are specified?
The applicable outline specifies 200 scored questions plus 30 additional unscored pilot questions, totaling 230. Its scored distribution is Patient Care 46, Safety 51 and Procedures 103. These correspond to 23%, 25.5% and 51.5%. The pilot questions do not contribute to the scored-category counts.
ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
How long is the examination, where is it administered and which question formats may appear?
The 2026 Primary Eligibility Pathway Handbook lists 230 minutes of test time for Radiation Therapy and a 250-minute appointment. ARRT administers the examination by computer at Pearson testing centers. Questions are predominantly single-best-answer multiple choice; published formats also include possible multiple-response, ordering, image-selection and video-associated questions. Random question order does not establish that an examination is adaptive.
How does the February 2027 blueprint change the distribution?
The replacement specifies Patient Care 47, Safety 51 and Procedures 102 of 200 scored questions, with another 30 unscored pilot questions. Its detailed scope also changes. Candidates testing from February 1, 2027 should study that complete replacement outline rather than treating this guide's weighting as their applicable blueprint.
ARRT Radiation Therapy Examination Content Specifications: February 1, 2027
What scope boundaries and measurement conventions matter?
SI units are the principal radiation measurement units. Staging coverage concerns basic concepts rather than site-specific staging systems. Brachytherapy coverage emphasizes common uses, surrounding-tissue dose and radiation protection; specific procedures and isotope characteristics are excluded. Specific CPT codes are also excluded. These boundaries do not remove the other topics in the complete official outline.
ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
How should I use the practice test and calculation examples?
The 20 questions are independent, four-option, single-best-answer learning drills: five Patient Care, five Safety and ten Procedures. They do not reproduce official items, simulate an adaptive examination or predict a passing result. Calculation examples supply their own assumptions and data; their results are educational exercises rather than patient prescriptions or machine settings.
ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
This guide addresses ARRT's primary eligibility pathway for entry-level certification and registration in Radiation Therapy. These independent learning materials are not official ARRT examination items or endorsed by ARRT. The 60 concepts are selective; the complete applicable official outline defines the full examination scope. ARRT certification and registration should not be assumed to establish a jurisdiction's separate licensing requirements.
Outline used: Current on October 15, 2026: Radiation Therapy Examination Content Specifications, board approved January 2021, implemented January 1, 2022, document V 2021.02.25; applicable through January 31, 2027. The workbook label identifies this ARRT certification and registration examination. The replacement specifications implemented February 1, 2027 are future requirements and are not the weighting basis for this guide.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Patient Care23% (46 of 200 scored questions)
1.How does patient verification prevent treatment of the wrong person?
Patient verification links the person present to the intended treatment record, treatment site and prescription. Recognition, appointment order and room assignment cannot establish that link reliably. Compare the patient's identifiers with the authorized record using the department's identification procedure before setup and irradiation. A mismatch is a stopping point because an otherwise accurate plan becomes harmful when delivered to the wrong person. Resolve identity before proceeding to technical treatment checks.
Apply it
Two patients share a surname and attend consecutive appointments. One answers when called, but the stated birth date differs from the open record. Stop the workflow and establish the correct patient-record match before positioning.
Common pitfall: Familiarity can create false confidence. Knowing a patient's face does not establish that the treatment record currently displayed belongs to that patient.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
2.When must conflicting treatment instructions be reconciled?
The prescription, approved treatment plan and delivery instructions must describe a coherent intended treatment. A disagreement involving dose, site, fractionation, energy or accessories cannot be resolved by choosing whichever entry appears most convenient. Withhold irradiation while the responsible team establishes the authorized instruction and updates the affected records. The decisive cue is an unresolved conflict, even when the equipment accepts the parameters and a previous fraction used the same setup.
Apply it
Today's setup sheet specifies bolus, but a newly entered instruction appears to discontinue it without a completed approval trail. Hold treatment while the team verifies the intended change and reconciles the delivery documents.
Common pitfall: A record-and-verify system can reproduce an incorrect or outdated instruction consistently. Electronic acceptance does not establish that a disputed prescription change is authorized.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation · ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
3.How do daily and accumulated dose entries differ?
Daily target dose records the dose actually delivered for the relevant treatment day or fraction, while accumulated dose records the running delivered total for the defined course or target. The prescription states intent; it is not evidence that every planned fraction was delivered. Accurate records also identify fraction, date, energy, monitor units and relevant deviations. After an interruption, reconcile actual delivery before updating totals so omitted or duplicated dose is not concealed.
Apply it
A course has ten fully delivered fractions of 200 cGy each, followed by another complete 200 cGy fraction today. Record 200 cGy for today's fraction and 2200 cGy accumulated for that course.
Common pitfall: Do not calculate accumulated dose from scheduled appointments alone. Missed, partially delivered or modified fractions require reconciliation with the actual treatment delivery record.
ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
4.How does teach-back reveal misunderstanding?
Teach-back asks a patient to explain instructions in their own words or demonstrate the required action. It tests the clarity of the explanation rather than the patient's willingness to agree. Introduce it without blame, listen for specific gaps, explain those points again and reassess understanding. A correct explanation of the actual preparation or safety behavior is stronger evidence than a nod or a yes response to an understanding question.
Apply it
After explaining bladder preparation for simulation, ask the patient to describe what they will do before arriving. Their explanation omits a key step, so repeat that step plainly and ask them to explain the sequence again.
Common pitfall: Repeating the same technical wording more loudly may preserve the misunderstanding. Teach-back requires checking the patient's meaning, not simply obtaining agreement with the explanation.
5.Why does consent require more than an available signature?
Consent concerns the patient's authorization for the proposed care, including an opportunity to understand its purpose and ask questions. A signature documents part of that process but does not resolve a present refusal, an apparent misunderstanding or uncertainty about the proposed procedure. Recognize these cues before proceeding and involve the responsible clinician to clarify the decision. Protect privacy during the discussion and distinguish voluntary treatment participation from cooperation with a positioning aid.
Apply it
A patient with a signed consent form says they believed today's visit involved imaging only and declines irradiation. Pause treatment and arrange clarification with the responsible clinician before proceeding with the proposed therapeutic exposure.
Common pitfall: A signed form does not override a patient's current refusal. Likewise, a positioning device should not be used to substitute for unresolved treatment authorization.
ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
6.How are Standard Precautions and PPE selected?
Standard Precautions apply to every patient because infectious material may be present without a known diagnosis. Their application includes hand hygiene, safe handling of equipment and materials, and personal protective equipment selected for anticipated exposure. Gloves address likely hand contact with infectious material; gown and face or eye protection depend on expected splash or contamination risks. Transmission-based precautions add measures for particular transmission risks rather than replacing these baseline practices.
Apply it
A patient without a documented infection needs assistance with a leaking drainage container. Assess likely hand, clothing and facial exposure, select appropriate protection, contain the material and perform hand hygiene after removing protective equipment.
Common pitfall: An absent infection label does not justify abandoning precautions. Conversely, wearing every type of PPE for every interaction ignores the exposure-based selection principle.
7.When is hand hygiene needed around glove use?
Gloves reduce direct hand contamination but do not eliminate the need for hand hygiene. Clean hands before donning gloves when indicated for patient care and immediately after removal, because hands may become contaminated through defects or during removal. Change gloves between patients and when moving from contaminated to clean tasks as appropriate. The key distinction is that a glove is a task-specific barrier, whereas hand hygiene removes or reduces contamination on the hands.
Apply it
After removing gloves used during patient contact, a therapist prepares to handle the next patient's immobilization device. Perform hand hygiene before the clean interaction; putting on another pair alone does not complete the transition.
Common pitfall: Continuing in the same gloves can transfer organisms to keyboards, positioning aids and other patients. Clean-looking gloves do not establish a clean surface.
8.How should reusable positioning equipment be prepared between patients?
Reusable patient-care equipment can transfer microorganisms through contaminated contact surfaces. Clean and disinfect shared equipment between patients using a process appropriate to the device and the manufacturer's instructions. Cleaning removes soil that can interfere with disinfection; disinfection then reduces relevant microorganisms. Preserve required disinfectant contact conditions and material compatibility. A surface that looks clean is not necessarily ready for reuse, and single-patient equipment should remain correctly identified and stored.
Apply it
A shared knee support has visible residue after treatment. Remove the soil and disinfect it using the approved compatible process before the next patient, including the required wet contact time for the chosen product.
Common pitfall: A quick dry wipe may improve appearance without completing disinfection. Do not substitute visual cleanliness for the required cleaning and disinfection process between patients.
9.Which contrast extravasation findings suggest severe injury?
Contrast extravasation places injected contrast outside the vessel. Stop the injection immediately and arrange clinical assessment. Severe or progressive pain, decreased capillary refill, altered sensation, worsening swelling, reduced movement, blistering or ulceration are warning findings that warrant urgent surgical consultation through the responsible clinician. These findings can indicate neurovascular compromise or significant tissue injury. Base escalation on clinical severity and progression rather than an estimated extravasated-volume threshold; a modest volume does not exclude serious harm.
Apply it
After contrast leaks into the forearm, the patient develops increasing pain, finger tingling and delayed capillary refill. Stop injection immediately if it is ongoing, obtain urgent clinical assessment and alert the responsible clinician to arrange urgent surgical consultation for these neurovascular warning findings.
Common pitfall: A volume threshold alone can miss serious injury. Progressive pain, altered sensation or impaired perfusion warrants urgent surgical consultation rather than observation based on an apparently modest leaked volume.
10.How should changing fatigue be assessed during treatment?
Fatigue can develop during radiation therapy, but its severity and timing vary among patients. Assess change from the patient's baseline, its effect on daily activity and accompanying symptoms rather than assuming an identical expected course. Treatment area, general health and other cancer treatments can influence the experience. A substantial new decline requires communication and assessment, particularly when it threatens safe transfers, treatment positioning, nutrition or the ability to complete ordinary activities.
Apply it
A patient who previously walked independently now needs help reaching the treatment couch and reports a sharp decline in energy. Document the change, provide safe assistance and communicate it for assessment before assuming routine fatigue.
Common pitfall: Calling every decline an expected radiation effect can obscure another problem. Conversely, comparing one patient's energy with another's does not establish an appropriate baseline.
11.Why can head and neck treatment impair nutritional intake?
Radiation effects in the mouth and throat can include soreness, dry mouth, taste changes and difficulty swallowing. These effects can reduce eating and drinking even when appetite was previously adequate. Connect the symptom pattern to the treated anatomy, assess intake and weight changes, and communicate difficulties early so supportive care can be arranged. The important cue is a functional consequence, such as inability to swallow usual foods, rather than soreness considered in isolation.
Apply it
During head and neck treatment, a patient reports that swallowing has become painful and meals now consist of only a few sips. Assess intake and weight trends and promptly involve the treatment team and nutrition support.
Common pitfall: Advice to simply eat more does not address painful swallowing or reduced saliva. Nutritional difficulty may reflect treatment effects that need targeted clinical support.
12.Which bowel and urinary changes matter during pelvic treatment?
Pelvic irradiation can affect bowel and urinary structures within the treated region, producing symptoms such as diarrhea or urinary discomfort. Assess onset, severity, frequency and consequences, including reduced fluid intake or difficulty maintaining the prescribed preparation. Compare symptoms with baseline and communicate meaningful changes. The treatment area makes these effects plausible, but it does not prove that every new bowel or urinary complaint is caused by radiation or should be accepted without assessment.
Apply it
A patient receiving pelvic treatment reports new diarrhea and has stopped drinking to avoid bathroom visits. Document the symptoms and reduced intake, then alert the clinical team because both supportive care and preparation reliability may be affected.
Common pitfall: Automatically attributing all pelvic symptoms to expected toxicity can delay assessment. Symptom severity and changes from baseline matter more than the treatment-site label alone.
13.When can radiation-related adverse effects appear after treatment?
Some radiation effects occur during treatment or soon afterward, while others emerge months or years later. The affected tissues, dose and other treatment factors influence the pattern. An interval without symptoms does not exclude a later treatment-related problem. Follow-up assessment therefore considers prior irradiated regions and the timing of new symptoms without assuming causation. Distinguishing early from late effects helps explain why monitoring remains relevant after the last scheduled fraction has been delivered.
Apply it
A survivor develops a new functional complaint in a previously treated region long after therapy ended. Include the radiation history and symptom timing in communication with the clinician rather than dismissing a possible relationship because treatment is complete.
Common pitfall: Late effects are possible, but timing alone does not establish their cause. New symptoms still require assessment rather than automatic attribution to previous radiation treatment.
14.How does palliative intent change the treatment goal?
Palliative radiation aims to relieve symptoms or problems caused by cancer, such as pain from a tumor, rather than necessarily eradicate all disease. The intended benefit should guide the explanation of treatment and the assessment of response. Persistent cancer elsewhere does not by itself mean that a symptom-directed course failed. Clarify the documented goal and evaluate the relevant symptom, function or local problem while recognizing that treatment can still produce adverse effects.
Apply it
A patient receiving radiation for a painful bone metastasis asks why treatment is being offered despite disease at other sites. Explain the documented symptom-relief goal and ask how pain and daily function are changing.
Common pitfall: Palliative treatment does not mean treatment without benefit or monitoring. Equally, symptom relief should not be represented as a promise of eliminating all cancer.
Safety25.5% (51 of 200 scored questions)
15.What does a dose expressed in gray measure?
Gray is the SI unit of absorbed dose: one gray represents one joule of energy deposited per kilogram of material. One gray equals 100 centigray, so a 2 Gy absorbed dose is 200 cGy. Sievert is used for protection quantities such as dose equivalent and should not replace gray when describing a prescribed absorbed treatment dose. Identify the physical quantity before converting units; similar numerical values do not make different quantities interchangeable.
Apply it
A prescription states 1.8 Gy per fraction and the treatment record displays centigray. Convert this to 180 cGy per fraction while preserving the absorbed-dose quantity; do not relabel the result in sievert.
Common pitfall: Confusing gray with sievert changes the meaning of the entry. A correct decimal conversion cannot repair use of the wrong physical quantity or unit.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students · BIPM: Recommendation 1—Concerning the Sievert
16.How does distance change point-source radiation intensity?
For an ideal point source in free space, intensity varies inversely with the square of distance: I2 = I1 × (r1/r2)². Doubling distance reduces intensity to one quarter, not one half. The relationship describes geometric spreading and assumes other factors remain unchanged. It does not independently account for attenuation, scatter, patient depth or changes in beam output. State the source-to-measurement distances clearly before choosing the ratio and squaring it.
Apply it
An idealized point source produces a dose rate of 80 units at 1 m. At 2 m, with no attenuation or scatter changes, the predicted rate is 80 × (1/2)² = 20 units.
Common pitfall: Using a simple inverse-distance ratio misses the squared dependence. Applying the same calculation to a full patient-dose problem can also omit essential attenuation and scatter factors.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
17.How does a half-value layer describe attenuation?
A half-value layer is the thickness of a specified material that reduces a beam's intensity to half under stated measurement conditions. For a monoenergetic narrow beam with unchanged attenuation properties, successive half-value layers multiply the transmitted fraction: two leave one quarter and three leave one eighth. Material and beam quality matter. Broad-beam scatter and beam hardening can change practical behavior, so a memorized thickness cannot be transferred indiscriminately between energies or shielding materials.
Apply it
A simplified narrow-beam problem specifies a constant half-value layer and asks for transmission through three such layers. Multiply one half three times to obtain one eighth, or 12.5%, of the original intensity.
Common pitfall: Half-value layers reduce the remaining intensity multiplicatively, not by subtracting half the original repeatedly. Their physical thickness depends on the material and radiation quality.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
18.Which interaction distinguishes Compton scattering from photoelectric absorption?
In Compton scattering, a photon transfers part of its energy to an electron and continues as a lower-energy scattered photon. In photoelectric absorption, the incident photon is absorbed and an electron is ejected from a bound shell. The presence or absence of a surviving incident photon distinguishes the mechanisms. Their relative importance depends on photon energy and material properties; Compton interactions are especially important for energy transfer in soft tissue at megavoltage therapy energies.
Apply it
An interaction diagram shows an ejected electron and a deflected photon with less energy than the incoming photon. Identify Compton scattering because the photon survives with changed direction and energy after transferring energy to the electron.
Common pitfall: An ejected electron alone does not distinguish these interactions. Look for the outgoing scattered photon and consider the incident energy and material before selecting the mechanism.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
19.What is clonogenic cell death?
Clonogenic death is the permanent loss of a cell's ability to reproduce sufficiently to form a colony. An irradiated cell may remain metabolically active or appear intact for a time while having lost reproductive capacity. This endpoint is central to tumor control because surviving clonogenic cells can repopulate disease. Immediate cell disappearance or visible tumor shrinkage is therefore an imperfect measure of the biological effect produced by a radiation exposure on reproductive survival.
Apply it
After irradiation, cultured tumor cells remain visible, but many cannot produce colonies during subsequent growth. Interpret the reduced colony formation as loss of clonogenic survival rather than concluding that unchanged immediate cell appearance means no radiation effect.
Common pitfall: Equating cell death only with immediate membrane breakdown misses reproductive death. Tumor size shortly after irradiation also does not directly measure the number of surviving clonogens.
IAEA: Radiotherapy in Cancer Care—Facing the Global Challenge
20.Why does oxygen increase sensitivity to low-LET radiation?
Low-LET radiation causes much of its biological damage through reactive species generated by water radiolysis. Oxygen can react with radiation-induced molecular damage and make it less chemically reversible, a process described as oxygen fixation. Consequently, hypoxic cells may be more resistant than otherwise comparable oxygenated cells. The relevant oxygen availability is around irradiation, and the effect should not be confused with a change in the physical absorbed dose delivered to the tissue.
Apply it
Two otherwise comparable cell populations receive the same low-LET absorbed dose, but one is hypoxic during irradiation. Expect greater survival in the hypoxic population because less damage is chemically fixed by oxygen under those conditions.
Common pitfall: Oxygen changes biological response rather than simply increasing the prescribed physical dose. The oxygen effect is also not identical across all radiation qualities and exposure conditions.
IAEA: Radiotherapy in Cancer Care—Facing the Global Challenge
21.Why can intervals between fractions reduce some normal-tissue injury?
Cells can repair some sublethal radiation damage during an interval between exposures. Separating dose into fractions can therefore reduce the interaction of unrepaired lesions compared with delivering the same total dose in one exposure. Repair is one contributor to fractionation effects, alongside other biological processes. The amount of recovery depends on tissue and timing; it does not mean all injury disappears or that therapists may independently shorten or lengthen the prescribed treatment schedule.
Apply it
A teaching comparison uses the same total dose delivered either once or in separated fractions. Explain that intervals may permit sublethal-damage repair, so identical physical totals need not produce identical biological effects in normal tissues.
Common pitfall: Repair is incomplete and tissue dependent. Treating every interval as full recovery can underestimate injury, especially when comparing different fraction sizes or altered treatment timing.
IAEA: Radiotherapy in Cancer Care—Facing the Global Challenge
22.How can reoxygenation affect later fractions?
Reoxygenation is the improvement in oxygen availability to some surviving tumor cells during a fractionated course. Changes in tumor cell burden, oxygen consumption or perfusion can allow previously hypoxic cells to become better oxygenated. Those cells may then become more sensitive to a later low-LET exposure. This process differs from repair: reoxygenation changes the oxygen environment of surviving cells, whereas repair changes the amount of residual radiation damage within cells.
Apply it
A tumor initially contains a resistant hypoxic population. After earlier fractions, some surviving cells have improved oxygen access. Explain why their response to a later low-LET fraction may differ even when the physical fraction dose is unchanged.
Common pitfall: Reoxygenation does not guarantee uniform tumor oxygenation or complete tumor control. Do not confuse it with repair, which may allow irradiated cells to survive damage.
IAEA: Radiotherapy in Cancer Care—Facing the Global Challenge
23.How do time, distance and shielding reduce occupational exposure?
Occupational protection combines reducing time near an active source, increasing appropriate distance and placing suitable shielding between the source and personnel. These controls act through different mechanisms and should be planned together. Distance benefits depend on source geometry, while shielding effectiveness depends on radiation type, energy and material. Remote handling and protected work locations can reduce exposure without compromising patient care. A personal dosimeter records exposure information but does not serve as one of these barriers.
Apply it
Before a necessary task near a radiation source, organize tools and the work sequence, use the designated remote handling method and maintain the prescribed shielded position. These preparations reduce avoidable time and proximity during the task.
Common pitfall: Standing farther away does not justify ignoring designated shielding or access controls. Likewise, wearing a dosimeter does not compensate for an unnecessarily prolonged exposure near a source.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
24.What can a personal dosimeter establish?
A personal dosimeter provides information about radiation exposure at its worn location over its monitoring interval or operating period. Proper assignment, placement, storage and review are necessary for meaningful records. It does not shield the wearer and does not directly prove that every organ received the same dose as the badge reading. An unexpected result requires investigation of work conditions and badge handling rather than automatic dismissal or an unsupported assumption about its cause.
Apply it
A monitoring report shows an unexpected increase for one therapist. Review the assigned badge's use, storage and relevant work activities through the radiation protection process rather than assuming that the badge itself prevented any significant exposure.
Common pitfall: Treating a dosimeter as protective equipment confuses measurement with exposure control. Sharing badges or storing them near a source can also undermine interpretation of individual records.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
25.Why must a failed treatment-room interlock stop clinical use?
A treatment-room door interlock is an engineered access safeguard that prevents or interrupts irradiation under specified unsafe access conditions. A failed check means that an intended protective layer is unavailable. Remove the equipment from clinical use through the established fault-management process, document the failure and obtain authorized correction and release. Staff vigilance is not an equivalent substitute because the interlock is designed to protect against foreseeable entry or workflow errors during treatment.
Apply it
During startup testing, opening the treatment-room door fails to produce the expected beam interruption. Do not begin patient treatments; report the fault and require the prescribed repair, verification and release process before clinical operation resumes.
Common pitfall: Posting a staff member at the door is a tempting workaround, but it does not restore the tested engineered safeguard or justify bypassing its failure.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
26.Why are visual and audio patient monitoring both important?
During remote treatment delivery, visual monitoring supports recognition of movement or visible distress, while audio communication allows patients to report problems that may not be apparent on a camera. Both functions contribute to detecting unsafe changes promptly. Verify their operation as required before treatment and respond to loss of monitoring through the established safety process. Immobilization reduces movement but does not eliminate discomfort, medical events or the need for communication throughout beam delivery.
Apply it
The patient remains visible on the treatment camera, but the communication system stops working before irradiation. Restore the required monitoring capability through the approved process instead of assuming that a clear camera image provides equivalent protection.
Common pitfall: A still patient is not necessarily comfortable or medically stable. Visual observation alone can miss an urgent complaint, and immobilization does not replace ongoing patient monitoring.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
27.How do output and geometric checks detect different treatment risks?
Output verification assesses the relationship between machine delivery and radiation dose under defined conditions. Geometric checks assess matters such as laser alignment, field agreement and mechanical positioning. A machine can satisfy one category while failing another, so a normal output result cannot establish correct localization. Evaluate results against the applicable action criteria, document them and follow the specified response to deviations. Clinical readiness requires the relevant safety, dosimetric and geometric checks to be acceptable.
Apply it
Morning output is acceptable, but a laser alignment check exceeds the department's action criterion. Treat the alignment result as a separate unresolved fault and follow the prescribed response before relying on that laser for patient localization.
Common pitfall: One reassuring measurement cannot certify the entire machine. Avoid averaging unrelated failures into an overall impression that equipment performance is close enough for treatment use.
IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation · IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
28.How should equipment with unknown MR safety status be handled?
Equipment with unknown MR safety status should be treated as unsafe for the MR environment until its status is established. An item's appearance, routine use elsewhere or lack of obvious magnetic attraction does not establish safety. MR hazards include displacement, heating and malfunction under relevant conditions. Keep the item outside the controlled MR environment and obtain identification and appropriate safety information rather than improvising a trial near the scanner or relying on another device's labeling.
Apply it
A patient arrives for MR-based planning with an unfamiliar portable pump that has no confirmed MR labeling. Keep the pump outside the controlled MR area while qualified personnel identify it and establish an appropriate safe arrangement.
Common pitfall: An object that seems nonmagnetic may still heat or malfunction. Visual inspection and informal attraction tests do not establish a complete MR safety classification for clinical use.
29.When is an MR Conditional device acceptable?
MR Conditional means that demonstrated safety depends on specified conditions of use. Those conditions may involve field strength, spatial gradient, radiofrequency exposure, device configuration and other restrictions. Confirm the exact device and every applicable condition before exposure. The label is not a general permission for any scanner or sequence. A condition that cannot be verified remains unresolved even when another patient with a similarly named device previously completed an examination without apparent harm.
Apply it
An implant's documentation permits scanning only under specified scanner and radiofrequency conditions. The available scanner meets the field-strength requirement, but the required exposure restriction has not been checked. Complete that verification before allowing the proposed scan.
Common pitfall: Matching field strength alone may satisfy only one condition. Similar model names and prior uneventful scans cannot substitute for checking the exact device's complete labeling.
Procedures51.5% (103 of 200 scored questions)
30.How does TNM describe the anatomical extent of cancer?
Stage describes the extent of cancer in the body. In TNM terminology, T addresses the primary tumor's size or local extent, N addresses regional lymph-node involvement and M addresses distant metastasis. These categories answer different anatomical questions and should not be substituted for one another. The meaning of detailed category thresholds depends on the cancer type. For this examination's basic staging scope, distinguish local, regional and distant disease without inventing site-specific stage assignments.
Apply it
A summary describes a primary lesion, involved regional nodes and a separate distant bone metastasis. Map those findings to T, N and M respectively rather than treating all spread beyond the primary lesion as nodal disease.
Common pitfall: A high grade does not establish distant spread, and regional nodal involvement is not automatically distant metastasis. Detailed stage grouping requires the appropriate site-specific system.
31.What does tumor grade reveal that stage does not?
Tumor grade describes microscopic features, including how abnormal cells appear and how closely they resemble the tissue of origin. Poor differentiation often suggests more aggressive biological behavior, although grading methods vary by cancer type. Stage instead describes anatomical extent. A tumor can therefore be localized and high grade, or more extensive with a different grade. Read pathology and staging information as complementary descriptions rather than attempting to infer one directly from the other.
Apply it
A pathology report describes a poorly differentiated tumor, while imaging shows disease confined to its primary location. Recognize high-grade microscopic features without concluding that distant metastasis is present solely because the cells look very abnormal.
Common pitfall: The words aggressive and advanced can be misleading when used loosely. Microscopic abnormality supports grade assessment; documented anatomical spread is needed to establish stage information.
32.Which head and neck structures connect localization with functional risk?
Parotid glands lie in front of and just below the ears; submandibular glands lie below the jaw; sublingual glands lie beneath the tongue in the mouth floor. These glands produce saliva, so irradiation can contribute to dry mouth and impaired eating. The pharynx extends from behind the nose toward the esophagus: its nasopharynx is behind the nose, its oropharynx includes the soft palate, tongue base and tonsils, and its hypopharynx is the lower portion. Injury along this swallowing passage can impair swallowing. The larynx lies just below the pharynx, contains the vocal cords and has an epiglottis that helps prevent food entering the airway; dysfunction can affect voice and airway protection. Anatomical references: [NCI Salivary Gland Cancer Treatment](https://www.cancer.gov/types/head-and-neck/patient/adult/salivary-gland-treatment-pdq) and [NCI Head and Neck Cancers](https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet).
Apply it
A planning target involves the right tonsil and tongue base. These landmarks localize it to the oropharynx rather than the oral tongue or larynx. Identify the adjacent swallowing passage and separately review the parotid near the ear and submandibular gland below the jaw. Interpret their spatial dose distributions to distinguish swallowing risk from salivary injury; a good external neck alignment does not establish these internal relationships.
Common pitfall: The front two-thirds of the tongue belongs to the oral cavity, while the tongue base belongs to the oropharynx. Do not confuse salivary glands with the swallowing passage or infer organ dose from proximity alone.
NCI: Radiation Therapy Side Effects · IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
33.Why must thoracic localization distinguish tumor, lung and mediastinal structures?
Thoracic treatment places moving targets near normal lung and structures such as the esophagus, heart and spinal cord. Sectional anatomy helps distinguish these tissues and assess whether reference landmarks represent the target adequately. Respiratory motion and tissue-density differences also affect planning and localization. A target's apparent alignment with bone does not prove that its soft-tissue position is correct. Evaluate the approved target relationship and relevant organs rather than treating the thorax as a uniform volume.
Apply it
Verification imaging shows matching vertebrae, but a lung target is displaced relative to its planned soft-tissue position. Review the target and respiratory context using the approved localization method instead of accepting the vertebral match as sufficient.
Common pitfall: Bone can be a useful reference without being a perfect target surrogate. Normal lung, tumor and mediastinal organs have different anatomical and treatment-planning roles.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice · IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
34.How can pelvic organ filling alter treatment anatomy?
The pelvis contains mobile or deformable soft-tissue structures whose relationships can change with bladder and bowel filling. Consequently, reproducing skin marks or pelvic bone alignment does not guarantee reproduction of the planned internal geometry. Preparation instructions and treatment imaging help assess the relevant anatomy. When a significant difference appears, use the approved assessment and correction pathway. A rigid couch translation cannot necessarily correct deformation or every change in the relationship between target and neighboring organs.
Apply it
A pelvic verification image shows satisfactory bone alignment but markedly different bladder filling and altered target position. Assess the preparation and soft-tissue relationship under the treatment protocol before assuming a single couch shift restores the planned anatomy.
Common pitfall: A geometric correction can align one structure while worsening another. Do not treat internal deformation as though the entire pelvis had moved as one rigid object.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
35.How are regional lymphatic spread and distant metastasis distinguished?
Regional lymph nodes are defined in relation to the primary cancer site, while distant metastasis represents spread to distant sites under the relevant staging system. Lymphatic anatomy helps explain patterns of regional involvement and why nodal regions may be considered during planning. Physical closeness alone does not determine whether a node is regional. Use the primary-site context and documented classification rather than assuming that every involved lymph node belongs in the same staging category.
Apply it
A record lists both regional nodal involvement and a distant organ lesion. Keep the nodal and distant findings distinct when reviewing disease extent, and confirm any uncertain node classification using the documented primary-site staging assessment.
Common pitfall: All lymph-node disease is not automatically regional. Conversely, an involved regional node does not by itself establish distant metastasis or determine the entire treatment volume.
NCI: Cancer Staging · IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
36.Which symptoms raise concern for spinal cord compression?
Spinal cord compression can produce back pain, weakness, sensory changes and loss of bladder or bowel control. In a patient with cancer, new neurological deficits or bladder and bowel changes are particularly concerning and require urgent assessment. The key is the symptom combination and progression, not waiting for every possible sign. Recognize the emergency pattern, stop routine assumptions about treatment tolerance and promptly activate the appropriate clinical response without attempting to establish the diagnosis independently.
Apply it
A patient awaiting treatment reports new leg weakness and difficulty controlling urination after worsening back pain. Escalate immediately for urgent clinical assessment rather than placing the patient into the usual treatment queue and reassessing after irradiation.
Common pitfall: Attributing new weakness to fatigue can delay recognition of a neurological emergency. Absence of one classic symptom does not safely exclude spinal cord compression.
37.What belongs in the gross tumor volume?
The gross tumor volume, or GTV, represents clinically demonstrable gross disease established through appropriate examination and imaging information. It describes disease that can be identified rather than a geometric allowance for setup uncertainty. Imaging quality, modality and clinical findings influence its definition. The GTV is therefore conceptually distinct from the clinical target volume and planning target volume. A region added only to account for possible microscopic extension should not be described as visible gross tumor.
Apply it
Planning images show a discrete mass, while the clinician also includes adjacent tissue at risk for microscopic involvement. Identify the demonstrable mass as GTV and keep the additional clinically indicated region conceptually separate from gross disease.
Common pitfall: The GTV is not the entire treatment field. Neither a setup margin nor every region receiving appreciable dose becomes gross tumor simply because it is irradiated.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
38.Why can the clinical target volume extend beyond visible disease?
The clinical target volume, or CTV, includes tissue requiring treatment because it contains demonstrated disease or clinically relevant suspected microscopic involvement. Its definition is a clinical judgment informed by disease patterns and anatomy. It may extend beyond the visible GTV, and it can exist after gross disease has been removed. This biological and anatomical purpose differs from the PTV's geometric purpose. Do not justify a CTV expansion solely by daily positioning variability.
Apply it
After surgery removes the visible lesion, the radiation oncologist defines a region at risk for residual microscopic disease. That region can be a CTV even though there is no remaining visible mass to contour as gross tumor.
Common pitfall: No visible tumor does not mean no clinical target. Conversely, adding tissue because the patient may shift is a planning-uncertainty issue rather than evidence of microscopic disease.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
39.How does the planning target volume address uncertainty?
The planning target volume, or PTV, is a geometric planning concept used to support adequate dose coverage of the CTV despite relevant positioning and motion uncertainties. It does not describe an additional layer of proven cancer. Margin design depends on the uncertainties remaining under the actual immobilization, imaging and correction strategy. Better localization can reduce some uncertainty but does not automatically remove motion, deformation or residual error, so a PTV cannot be discarded merely because imaging is available.
Apply it
A department introduces image-guided correction and reviews its remaining setup and motion uncertainties. Those measured uncertainties inform any approved PTV margin change; the presence of a new imaging system alone does not define a safe replacement margin.
Common pitfall: A PTV is not a guarantee that every possible displacement is covered. It also should not be interpreted as gross or microscopic disease extending throughout the margin.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students · IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
40.Why must simulation reproduce the intended treatment position?
Simulation establishes the anatomical and geometric information used to plan treatment. Position, immobilization, accessories and preparation should represent the conditions intended for delivery because they affect target location and beam paths. Document the setup sufficiently for another therapist to reproduce it. A comfortable diagnostic position is not automatically a suitable treatment position. If a meaningful setup feature changes after planning, assess its effect rather than assuming the original dose distribution remains applicable without review.
Apply it
Simulation uses a particular arm position and indexed support, but the patient arrives for treatment unable to reproduce them. Seek assessment of the changed geometry before using the original plan with an improvised position and support arrangement.
Common pitfall: Matching the general body orientation is insufficient when support height, arm placement or accessories alter anatomy. Simulation documentation must capture the reproducible treatment configuration.
NCI: External Beam Radiation Therapy for Cancer · IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
41.How do immobilization, indexing and reference marks work together?
Immobilization limits unwanted movement and supports a reproducible position. Indexing places equipment consistently relative to the couch, while reference marks help reproduce the patient's initial alignment. These tools control different parts of the setup chain and work best when their configuration is documented. None independently establishes internal target location. A changed device fit or indexing position is a meaningful discrepancy because matching skin marks can coexist with a different body shape or internal anatomy.
Apply it
A mask is attached at the documented couch index, but it fits much more loosely after the patient loses weight. Review the fit and localization rather than relying on the unchanged index and visible reference marks alone.
Common pitfall: Reference marks support initial setup but are not a substitute for prescribed verification imaging. Correct equipment indexing also does not prove that the patient fits correctly inside the device.
NCI: External Beam Radiation Therapy for Cancer · IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
42.How should image registration be judged?
Image registration relates verification images to the reference dataset so anatomical alignment can be assessed. Judge the result using the clinically intended target or surrogate and relevant surrounding structures, not only a numerical match score. Bone, soft tissue and external contours may disagree because of motion or deformation. Automated registration therefore requires appropriate review. A technically successful image match can still be clinically unsuitable if it aligns structures that do not adequately represent the treatment target.
Apply it
An automated pelvic registration aligns bone closely, but the prescribed soft-tissue target remains displaced. Review the target-based match under the approved protocol instead of accepting the automated result merely because its score appears favorable.
Common pitfall: A registration algorithm optimizes its selected image information, not an independent understanding of treatment intent. The chosen region and anatomical surrogate determine what its result means.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
43.Why must a calculated couch correction be verified?
A calculated correction must be translated into the correct machine coordinate system, applied to the intended patient and assessed for successful execution. Coordinate signs, patient orientation, couch motion and residual displacement can introduce errors after registration. Follow the approved correction and verification process, including repeat imaging when indicated by that process. A displayed shift value is an instruction or estimate, not proof that the patient now occupies the intended position for beam delivery.
Apply it
Registration indicates a lateral correction, but the couch readout changes in an unexpected direction after movement. Stop and verify orientation, coordinates and actual position through the approved process before concluding that the requested correction has been completed.
Common pitfall: Memorizing a direction rule without patient orientation can reverse a correction. Likewise, confirming that a number was entered does not verify the resulting anatomical alignment.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
44.How do systematic and random setup errors differ?
A systematic setup error is a persistent displacement component that recurs across fractions, whereas random error varies between fractions around the underlying setup position. Repeated displacement in the same direction suggests a reproducibility problem or consistent reference mismatch. Variable daily displacements suggest a different uncertainty pattern. Reviewing a series of observations helps distinguish them. Averaging measurements may reveal a systematic component, but it does not remove daily variability or justify ignoring required image-guided corrections.
Apply it
Verification images repeatedly show a similar displacement toward the same side over several fractions. Investigate a systematic setup issue, such as reference or device placement, rather than interpreting every observation as unrelated day-to-day variation.
Common pitfall: A near-zero average can hide large opposing daily errors. Conversely, repeated errors in one direction should not be dismissed simply because each is individually modest.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
45.How are SSD, SAD and target depth distinguished?
Source-to-surface distance, or SSD, ends at the patient's entrance surface. Source-to-axis distance, or SAD, ends at the machine's treatment axis or isocenter. Target depth describes the target's depth from the relevant surface along the specified geometry. These distances answer different questions and must match the calculation convention. In a simplified central-axis arrangement, a 100 cm source-to-target distance with 10 cm target depth corresponds to 90 cm SSD, not 100 cm SSD.
Apply it
An exercise places a central-axis target 8 cm beneath the entrance surface at a 100 cm source-to-target distance. Under the stated straight-line geometry, identify SSD as 92 cm and preserve the 100 cm distance to the target.
Common pitfall: Do not insert SAD into an SSD-based formula simply because both are lengths. Patient contour and off-axis geometry can also make an oversimplified depth subtraction inappropriate.
46.How is the equivalent square of a rectangular field calculated?
For a specified rectangular-field approximation, the equivalent-square side is 4A/P, where A is area and P is perimeter. For sides a and b, this becomes 2ab/(a+b). The result approximates selected dosimetric behavior of the rectangle using square-field data; it is not a claim that the shapes are geometrically identical. Use dimensions defined at the relevant plane and apply the approximation only within the calculation method's intended conditions, especially when shielding changes field shape.
Apply it
For an open 10 cm by 20 cm rectangle, area is 200 cm² and perimeter is 60 cm. The equivalent-square side is 4 × 200/60 = 13.33 cm under the stated approximation.
Common pitfall: The arithmetic mean gives 15 cm and the equal-area square gives about 14.14 cm; neither is the specified 4A/P equivalent-square calculation for this rectangle.
47.How do dose per monitor unit and required dose determine monitor units?
When the effective dose per monitor unit at the specified calculation point is known, required monitor units equal required dose divided by that dose per monitor unit. The denominator must represent the relevant energy, geometry, depth, field and modifiers. Reference output alone is not necessarily the dose per monitor unit at the target. Identify which correction factors are already included so that none are omitted or applied twice. Keep dose units consistent throughout the calculation.
Apply it
A teaching problem specifies 180 cGy required at a point and an effective dose per monitor unit of 0.90 cGy/MU, including all stated corrections. Calculate 180/0.90 = 200 MU without adding duplicate factors.
Common pitfall: Multiplying dose by dose per monitor unit produces the wrong dimensions. Using reference output without the required depth or modifier corrections can also understate the needed monitor units.
AAPM Report No. 258: Monitor Unit Calculations for External Photon and Electron Beams · AAPM Task Group 71: Monitor Unit Calculations for External Photon and Electron Beams—Argonne-hosted Full Report
48.What does percentage depth dose compare?
Percentage depth dose, or PDD, expresses dose at a specified depth as a percentage of dose at the reference depth of maximum dose for stated beam and irradiation conditions. A PDD of 70% means the depth dose is 0.70 times that reference dose, not that 70% of incident photons survive. PDD depends on factors including beam quality, depth, field size and SSD. Preserve those conditions when using tabulated data or interpreting a calculation.
Apply it
An educational problem gives 200 cGy at the stated maximum-dose reference and a PDD of 75% at the calculation depth under the same conditions. The corresponding depth dose is 200 × 0.75 = 150 cGy.
Common pitfall: PDD is a dose ratio, not a photon-transmission fraction. Do not mix a PDD table from one SSD or field condition with another without the required method.
49.What can a dose-volume histogram show and conceal?
A dose-volume histogram summarizes how much of a defined structure receives particular dose levels. On a cumulative DVH, a point represents the volume receiving at least the indicated dose. It is useful for comparing coverage and normal-tissue exposure but discards spatial location. Two distributions can have similar DVHs while placing a high-dose region in different anatomical locations. Interpret the curves with structure definitions and spatial dose displays rather than treating the histogram as a complete plan description.
Apply it
Two plans have almost identical target DVHs, but their dose maps place an underdosed region in different parts of the target. Review the spatial distributions before concluding that the plans provide equivalent clinically relevant target coverage.
Common pitfall: A favorable summary curve cannot locate a hotspot or cold spot. Confusing cumulative and differential DVHs can also reverse the meaning of the plotted volume.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
50.How do transmission factors change monitor-unit reasoning?
A beam modifier that transmits less dose per monitor unit reduces the effective dose per monitor unit at the calculation point when other relevant conditions are unchanged. Maintaining the same required dose then requires more monitor units. In a simplified multiplicative calculation, include the specified transmission factor in the dose-per-monitor-unit denominator. Verify whether the provided effective output already incorporates the modifier. The factor's definition and applicable geometry determine its correct use.
Apply it
An exercise gives 1.00 cGy/MU before a modifier and a modifier factor of 0.80, with other factors unity. For 160 cGy at the point, use 0.80 cGy/MU and calculate 200 MU.
Common pitfall: Multiplying required monitor units by a factor below one reverses the intended compensation. Applying a modifier factor twice can instead overestimate the monitor units required.
51.How does field weighting divide a prescribed point dose?
Field weighting describes the relative contribution assigned to treatment fields under the plan's stated convention. If weights are defined as dose contributions at a specified point, a 2:1 ratio divides the total into two thirds and one third at that point. The corresponding monitor units need not share that ratio because each field may have a different effective dose per monitor unit. Establish what the weights represent before translating them into dose or machine delivery quantities.
Apply it
A simplified plan assigns a 150 cGy point dose between two fields in a 2:1 dose-contribution ratio. Allocate 100 cGy and 50 cGy, then calculate each field's monitor units using its own effective dose per MU.
Common pitfall: A dose-weight ratio is not automatically an MU ratio. Different depths, modifiers or field conditions can require different monitor units for the same dose contribution.
52.Why is bolus placed on the patient?
Bolus is tissue-equivalent material placed on the patient to alter dose buildup or compensate for missing tissue according to the plan. With megavoltage photons, it can bring the buildup region toward the surface and increase surface dose. Its effect depends on thickness, coverage, fit, beam and treatment geometry. Verify the prescribed material and placement, including relevant gaps. Bolus is a planned dosimetric accessory, so adding or removing it changes more than patient comfort.
Apply it
A superficial target requires the planned bolus, but the accessory is absent at setup. Obtain the correct bolus and verify its fit rather than delivering the same monitor units without it and assuming target dose remains unchanged.
Common pitfall: Bolus is not interchangeable with an immobilization cushion. Air gaps and incorrect coverage can change its effect, and an unapproved substitution may alter the intended dose distribution.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
53.Why are electron beams useful for some superficial targets?
Electron beams have a limited useful penetration depth, with a relatively rapid dose falloff beyond their therapeutic range compared with penetrating photon beams. This can support treatment of suitable superficial targets while limiting deeper exposure. Energy, target depth, surface contour, field size and tissue heterogeneity influence the distribution. Limited range does not mean zero deep dose or automatic suitability for every skin lesion. The selected plan must still cover the target and account for nearby normal tissues.
Apply it
A teaching comparison involves a shallow target with a deeper structure to spare. Electrons may offer an appropriate depth-dose pattern, but confirm the target depth, surface shape and planned energy rather than selecting them solely from the word superficial.
Common pitfall: The electron beam's finite range does not guarantee complete target coverage or no dose beyond it. Irregular surfaces and tissue differences can change the expected distribution.
NCI: External Beam Radiation Therapy for Cancer · IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
54.Why can photon treatment irradiate tissue beyond the target?
Photon beams attenuate progressively rather than stopping at a sharply defined therapeutic range. A penetrating beam can therefore deliver dose on entry, within the target and beyond it. Multiple beam directions distribute these contributions to improve target coverage and normal-tissue sparing, but they do not eliminate all non-target exposure. Interpret dose maps across the full beam path. A beam shaped to the target's projection still deposits dose along tissues traversed before and after that projection.
Apply it
A patient asks whether a photon beam ends when it reaches the tumor. Explain that the plan accounts for dose throughout its path and uses beam arrangements to balance target coverage with exposure of surrounding normal tissues.
Common pitfall: A sharply shaped field edge in one view does not mean dose is confined to a three-dimensional tumor boundary. Projection shape and depth-dose behavior are different properties.
IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students · NCI: External Beam Radiation Therapy for Cancer
55.How does IMRT shape dose beyond simple field outlining?
Intensity-modulated radiation therapy varies fluence within treatment beams to create a planned composite dose distribution. This differs from using only a uniform beam intensity inside a shaped aperture. Modulation can improve dose conformity around complex targets and adjacent organs, but it increases the importance of accurate planning, delivery verification and localization. A highly conformal planned distribution is still vulnerable to setup error or anatomical change; modulation does not independently establish that the target is correctly positioned.
Apply it
A target curves around a nearby organ. An IMRT plan varies intensity across beams to balance coverage and sparing, while the treatment workflow separately verifies the patient's position and the approved delivery parameters before irradiation.
Common pitfall: IMRT describes modulation, not daily imaging. A plan can be intensity modulated without providing an automatic check that the target and neighboring organs match the planned geometry.
NCI: External Beam Radiation Therapy for Cancer · IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
56.How does IGRT support localization without replacing planning?
Image-guided radiation therapy uses imaging associated with treatment to assess the relationship between current anatomy and the reference plan. It can support corrections for identifiable localization errors and reveal changes requiring review. It does not automatically create a new approved dose distribution or correct every form of deformation and motion. Select the imaging method and anatomical match according to the target and protocol, then distinguish an acceptable setup correction from a change requiring broader clinical assessment.
Apply it
Daily imaging shows a small rigid displacement that fits the correction protocol on one day, but major anatomical deformation on another. Apply the approved correction pathway for the former and seek further assessment for the latter.
Common pitfall: More imaging does not itself guarantee better alignment. Image quality, registration choice, interpretation and correction verification determine whether the localization information improves the actual treatment.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
57.How does respiratory gating control when radiation is delivered?
Respiratory gating restricts beam delivery to a selected portion of the breathing cycle or motion signal. It aims to reduce the range of target positions exposed during beam-on time, rather than continuously irradiating throughout unrestricted breathing. The relationship between the monitored signal and internal target position must be established and maintained. Irregular breathing or a changed surrogate relationship can undermine the planned geometry, so gating requires its own verification and does not mean respiratory motion has disappeared.
Apply it
A lung treatment uses a defined respiratory window, but the patient's breathing becomes irregular and falls outside the accepted pattern. Pause and follow the gating assessment process rather than widening the window informally to complete treatment faster.
Common pitfall: An external respiratory trace is a surrogate, not direct proof of internal target position. Gating also does not mean every treatment beam must be delivered during breath-hold.
IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
58.How does brachytherapy differ from external-beam treatment?
Brachytherapy places a radiation source in or near the target rather than directing all radiation from an external treatment machine. Source proximity can create a steep dose gradient, so small changes in source-to-tissue distance can strongly affect dose. Surrounding normal tissues and radiation protection remain important. At this examination's specified level, emphasize the basic treatment concept, nearby-tissue exposure and protection principles rather than memorizing excluded procedure-specific details or isotope characteristics.
Apply it
A basic comparison places a source near a target in one approach and outside the patient in another. Identify the first as brachytherapy and explain why source position relative to adjacent tissues is an important dosimetric consideration.
Common pitfall: An internal source does not confine radiation exclusively to tumor cells. Nearby normal tissues can receive dose, and protection requirements depend on the actual source arrangement.
NCI: Brachytherapy to Treat Cancer · IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
59.What changes after a temporary brachytherapy source is removed?
After a temporary brachytherapy source has been removed and its removal verified, that source no longer irradiates the patient or exposes others from within the patient. An applicator remaining in place is not equivalent to an active radioactive source. This distinction does not apply automatically to permanent implants, where sources remain. Source accounting and the authorized confirmation process establish which situation exists; the patient's appearance or the presence of treatment hardware cannot do so independently.
Apply it
After a temporary treatment, a patient worries that an empty applicator will expose family members. Once the team has verified source removal, explain that the removed source is no longer present to emit radiation from the patient.
Common pitfall: Do not generalize temporary-source removal to permanent implants. Likewise, assume neither that every applicator is radioactive nor that source removal is complete without the required verification.
NCI: Brachytherapy to Treat Cancer · IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
60.Why does fraction size matter as well as total dose?
Fractionation divides a treatment course into separate exposures. Biological response depends on fraction size, number, timing and tissue characteristics, so equal total absorbed doses can produce different effects under different schedules. Interfraction intervals can permit repair, while other processes such as reoxygenation and repopulation also influence response. Verify the prescribed schedule rather than treating its arithmetic total as the only important feature. A missed fraction should not be compensated for by independently combining doses.
Apply it
A patient misses an appointment and asks to receive two fractions together the next day. Explain that changing fraction size changes the treatment schedule's biological meaning and requires an authorized clinical decision rather than simple arithmetic substitution.
Common pitfall: Equal total dose does not establish equal biological effect. Doubling one fraction to preserve the course total can change normal-tissue injury and target response.
NCI: External Beam Radiation Therapy for Cancer · IAEA: Radiotherapy in Cancer Care—Facing the Global Challenge
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the applicable blueprint to divide study time approximately 23% Patient Care, 25.5% Safety and 51.5% Procedures; expand beyond these selective concepts using every official subcategory.
- Practise stopping decisions: identity or prescription conflicts, failed interlocks, unverified MR conditions, concerning extravasation findings and new neurological deficits.
- Separate disease extent from microscopic grade, and distinguish GTV, CTV and PTV by the reason each volume exists.
- Connect sectional anatomy, immobilization, registration and correction verification; distinguish rigid displacement from deformation and respiratory motion.
- Write the quantity, units, geometry and included factors before every calculation involving inverse square, equivalent square, PDD, field weights or monitor units.
- Study the complete outline's additional material, including ethics, emergencies, pharmacology, blood studies, radiation interactions, instrumentation, site-specific anatomy and treatment accessories.
A practical preparation plan
1. Confirm the applicable outline
Match your examination date to the January 2022 or February 2027 implementation. For the outline used here, build a study grid with the three domains and all eight official subcategories.
2. Build a verification sequence
Explain aloud how you verify identity, authorization, prescription, setup, accessories, images, corrections and delivery records. For each step, name one discrepancy that must be resolved before irradiation.
3. Link anatomy to decisions
Review sectional anatomy across every listed treatment region. Identify targets, neighboring organs, relevant nodal regions and emergency symptom patterns, then connect them with localization and patient assessment.
4. Solve calculations with explicit assumptions
Practise unit conversion, inverse-square ratios, equivalent squares, PDD and simplified monitor-unit calculations. State whether output is reference or effective, and identify every included modifier before calculating.
5. Use errors to direct review
Complete the 20 drills without consulting the explanations. For each error, identify the missed cue and explain why the other options fail. Revisit the corresponding concept and official-outline subcategory.
6. Finish with full-scope recall
Use the flashcards for spaced recall, then audit the complete official outline for uncovered topics. Practise explaining mechanisms and stopping criteria rather than memorizing isolated terms or treating a short test score as pass readiness.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ARRT: Radiation Therapy
- ARRT Radiation Therapy Examination Content Specifications: January 1, 2022
- ARRT Radiation Therapy Examination Content Specifications: February 1, 2027
- IAEA: Radiation Oncology Physics—A Handbook for Teachers and Students
- IAEA: Radiotherapy in Cancer Care—Facing the Global Challenge
- IAEA: Introduction of Image Guided Radiotherapy into Clinical Practice
- IAEA SSG-46: Radiation Protection and Safety in Medical Uses of Ionizing Radiation
- AAPM Report No. 258: Monitor Unit Calculations for External Photon and Electron Beams
- AAPM Task Group 71: Monitor Unit Calculations for External Photon and Electron Beams—Argonne-hosted Full Report
- BIPM: Recommendation 1—Concerning the Sievert
- CDC: Clinical Safety—Hand Hygiene for Healthcare Workers
- CDC: Standard Precautions for All Patient Care
- AHRQ TeamSTEPPS: Tool—Teach-Back
- ACR Manual on Contrast Media
- FDA: MRI Information for Professionals
- NCI: Radiation Therapy for Cancer
- NCI: External Beam Radiation Therapy for Cancer
- NCI: Brachytherapy to Treat Cancer
- NCI: Radiation Therapy Side Effects
- NCI: Cancer Staging
- NCI: Tumor Grade
- NCI Dictionary: Spinal Cord Compression
- Handbooks - ARRT
- arrt-primary-handbook.pdf
- Benefits and Risks | FDA
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.